About Keyan Salari, MD, PhD

Clinical Interests:

Treats:

Locations

Mass General Cancer Center: Center for Genitourinary Cancers
55 Fruit St.
Boston, MA 02114
Phone: 617-724-4000

Mass General Urology
165 Cambridge St.
7th Floor
Boston, MA 02114
Phone: 857-238-3838

Medical Education

  • MD, Stanford University
  • Residency, Massachusetts General Hospital
  • Fellowship, Memorial Sloan Kettering Cancer Center

American Board Certifications

  • Urology, American Board of Urology

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Publications

    • He MX, Cuoco MS, Crowdis J, et al. Transcriptional mediators of treatment resistance in lethal prostate cancer. Nat Med. 2021 Mar;27(3):426-433. Epub 2021 Mar 4.
    • AlDubayan SH, Conway JR, Camp SY, et al. Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma. JAMA. 2020 Nov 17;324(19):1957-1969. doi: 10.1001/jama.2020.20457.
    • Liu D, Shoag J, Poliak D, et al. Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes. Nat Commun. 2020 Apr 24;11(1):1987.
    • Hanna N, Wszolek MF, Mojtahed A, et al. Multiparametric MRI/ultrasound fusion biopsy improves but does not replace standard template biopsy for the detection of prostate cancer. J Urol. 2019 May 30.
    • Salari K, Kuppermann D, Preston MA, et al. Active Surveillance of Prostate Cancer is a Viable Option in Men Younger Than 60 Years. J Urol. 2019 Apr;201(4):721-727.
    • Wang Z, Hu L, Salari K, et al. Androgenic to Estrogenic Switch in Human Adult Prostate Gland as a result of Epigenetic Silencing of Steroid 5-α Reductase 2. J Pathol. 2017 Dec;243(4):457-467.
    • Cuff J, Salari K, Esheba GE, et al. Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis. PLoS ONE 2013 Sep 9;8(9):e74562.
    • Salari K, Spulak ME, Cuff J, et al. CDX2 is an amplified lineage-survival oncogene in colorectal cancer. Proc Natl Acad Sci USA. 2012 Nov 13;109(46):E3196-205.

Reviews: Comments and Ratings

4.9out of 5(145 Ratings, 55 Comments)

June 2025

He was great


June 2025

I had a great experience with this care provider and their team.


June 2025

Clear explanation of reasons for the visit and what we would accomplish. Receptive to my questions and gave clear answers. An excellent experience all around.


June 2025

Everyone was excellent to work with.


June 2025

Communicated everything to me in a way that was easy to understand.


June 2025

This was a very pleasant experience


May 2025

Pleasant, thorough, caring, very nice person, impressive credentials


May 2025

He explained everything that we should do so that we understood all that was necessary


May 2025

Extremely professional and courteous


May 2025

Very caring and concerned Dr.

View More
Ratings and Comments Powered by NRC Health